BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 33892887)

  • 1. Updates on conservative management of endometrial cancer in patients younger than 45 years.
    Lucchini SM; Esteban A; Nigra MA; Palacios AT; Alzate-Granados JP; Borla HF
    Gynecol Oncol; 2021 Jun; 161(3):802-809. PubMed ID: 33892887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysteroscopic Endometrial Focal Resection followed by Levonorgestrel Intrauterine Device Insertion as a Fertility-Sparing Treatment of Atypical Endometrial Hyperplasia and Early Endometrial Cancer: A Retrospective Study.
    Giampaolino P; Di Spiezio Sardo A; Mollo A; Raffone A; Travaglino A; Boccellino A; Zizolfi B; Insabato L; Zullo F; De Placido G; Bifulco G
    J Minim Invasive Gynecol; 2019; 26(4):648-656. PubMed ID: 30017893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hysteroscopic Resection in Fertility-Sparing Surgery for Atypical Hyperplasia and Endometrial Cancer: Safety and Efficacy.
    De Marzi P; Bergamini A; Luchini S; Petrone M; Taccagni GL; Mangili G; Colombo G; Candiani M
    J Minim Invasive Gynecol; 2015; 22(7):1178-82. PubMed ID: 26092080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.
    Mittermeier T; Farrant C; Wise MR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD012658. PubMed ID: 32909630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fertility-preserving treatment of stage IA, well-differentiated endometrial carcinoma in young women with hysteroscopic resection and high-dose progesterone therapy.
    Yang HC; Liu JC; Liu FS
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):90-93. PubMed ID: 30638488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility-Preserving Treatment in Young Women With Grade 1 Presumed Stage IA Endometrial Adenocarcinoma: A Meta-Analysis.
    Fan Z; Li H; Hu R; Liu Y; Liu X; Gu L
    Int J Gynecol Cancer; 2018 Feb; 28(2):385-393. PubMed ID: 29266019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fertility-sparing management of low-grade endometrial stromal sarcoma: analysis of an institutional series and review of the literature.
    Laurelli G; Falcone F; Scaffa C; Messalli EM; Del Giudice M; Losito S; Greggi S
    Eur J Obstet Gynecol Reprod Biol; 2015 Dec; 195():61-66. PubMed ID: 26476800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fertility preserving treatment with hysteroscopic resection followed by progestin therapy in young women with early endometrial cancer.
    Falcone F; Laurelli G; Losito S; Di Napoli M; Granata V; Greggi S
    J Gynecol Oncol; 2017 Jan; 28(1):e2. PubMed ID: 27670256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fertility sparing treatment in patients with endometrial cancer (FERT-ENC): a multicentric retrospective study from the Spanish Investigational Network Gynecologic Oncology Group (SPAIN-GOG).
    Lago V; Marina T; Laseca Modrego M; Gil-Ibañez B; Rodriguez JR; Domingo J; Minig L; Padilla-Iserte P; Arencibia Sánchez O; Sala Ferichola M; Munmanny M; Martín Salamanca B; Iacoponi S; Cabrera S; Coronado P; Utrilla-Layna J; Bataller Á; Fiol G; Corbalán S; Espinosa E; Gil-Moreno A; Domingo S;
    Arch Gynecol Obstet; 2022 Sep; 306(3):821-828. PubMed ID: 35122158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Updates on Conservative Management of Endometrial Cancer.
    Corzo C; Barrientos Santillan N; Westin SN; Ramirez PT
    J Minim Invasive Gynecol; 2018 Feb; 25(2):308-313. PubMed ID: 28782618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fertility-sparing approach for endometrial cancer: the role of office hysteroscopy.
    Carugno J; Wong A
    Minim Invasive Ther Allied Technol; 2021 Oct; 30(5):296-303. PubMed ID: 34292797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uterine sparing management in patients with endometrial cancer: a narrative literature review.
    Zisi M; Zygouris D; Tsonis O; Papadimitriou S; George M; Kalantaridou S; Paschopoulos M
    J Obstet Gynaecol; 2022 Jul; 42(5):823-829. PubMed ID: 34989284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral and intrauterine progestogens for atypical endometrial hyperplasia.
    Luo L; Luo B; Zheng Y; Zhang H; Li J; Sidell N
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD009458. PubMed ID: 30521671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reproductive and oncologic outcomes after progestin therapy for endometrial complex atypical hyperplasia or carcinoma.
    Kudesia R; Singer T; Caputo TA; Holcomb KM; Kligman I; Rosenwaks Z; Gupta D
    Am J Obstet Gynecol; 2014 Mar; 210(3):255.e1-4. PubMed ID: 24211482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.
    Raffone A; Travaglino A; Saccone G; Alviggi C; Mascolo M; De Placido G; Insabato L; Mollo A; Zullo F
    Acta Obstet Gynecol Scand; 2019 Jul; 98(7):842-855. PubMed ID: 30714089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The results of different fertility-sparing treatment modalities and obstetric outcomes in patients with early endometrial cancer and atypical endometrial hyperplasia: Case series of 30 patients and systematic review.
    Piatek S; Michalski W; Sobiczewski P; Bidzinski M; Szewczyk G
    Eur J Obstet Gynecol Reprod Biol; 2021 Aug; 263():139-147. PubMed ID: 34214800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fertility-sparing management for endometrial cancer: review of the literature.
    Garzon S; Uccella S; Zorzato PC; Bosco M; Franchi MP; Student V; Mariani A
    Minerva Med; 2021 Feb; 112(1):55-69. PubMed ID: 33205638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of hysteroscopic endometrectomy in the conservative treatment of early endometrial cancer and atypical hyperplasia in fertile women.
    Atallah D; El Kassis N; Safi J; El Hachem H; Chahine G; Moubarak M
    Arch Gynecol Obstet; 2021 Nov; 304(5):1299-1305. PubMed ID: 33830345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Live births and maintenance with levonorgestrel IUD improve disease-free survival after fertility-sparing treatment of atypical hyperplasia and early endometrial cancer.
    Novikova OV; Nosov VB; Panov VA; Novikova EG; Krasnopolskaya KV; Andreeva YY; Shevchuk AS
    Gynecol Oncol; 2021 Apr; 161(1):152-159. PubMed ID: 33461741
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chances of pregnancy and live birth among women undergoing conservative management of early-stage endometrial cancer: a systematic review and meta-analysis.
    Herrera Cappelletti E; Humann J; Torrejón R; Gambadauro P
    Hum Reprod Update; 2022 Feb; 28(2):282-295. PubMed ID: 34935045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.